Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Archives of General Psychiatry
|
October 1, 1993
Strong inference, theory testing, and the neuroanatomy of schizophrenia
W T Carpenter, R W Buchanan, B Kirkpatrick, et al.
Lancet (London, England)
|
October 23, 1976
Depression associated with oral choline
C Tamminga, R C Smith, S Chang, et al.
Psychopharmacology Bulletin
|
January 1, 1989
Oculomotor abnormalities and their clinical correlates in schizophrenia
G Thaker, B Kirkpatrick, R W Buchanan, et al.
Pharmacological Research Communications
|
May 1, 1985
Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration
E A Parati, M Parenti, V Locatelli, et al.
Schizophrenia Research
|
October 11, 1991
Psychopathology and the question of neurodevelopmental or neurodegenerative disorder
W T Carpenter, R W Buchanan, A Breier, et al.
The American Journal of Psychiatry
|
May 1, 1977
Postsynaptic supersensitivity in schizophrenia
G N Pandey, D L Garver, C Tamminga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1991
Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human
A J Bean, R Elde, Y H Cao, et al.
Clinical Neuropharmacology
|
January 1, 1986
GABA-agonist therapy for Alzheimer's disease
E Mohr, G Bruno, N Foster, et al.
Molecular Psychiatry
|
February 13, 2013
An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors
R N Arey, J F Enwright, S M Spencer, et al.
Psychiatry Research
|
July 1, 1983
Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients
J I Nurnberger, D C Jimerson, S Simmons-Alling, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Archives of General Psychiatry
|
October 1, 1993
Strong inference, theory testing, and the neuroanatomy of schizophrenia
W T Carpenter, R W Buchanan, B Kirkpatrick, et al.
Lancet (London, England)
|
October 23, 1976
Depression associated with oral choline
C Tamminga, R C Smith, S Chang, et al.
Psychopharmacology Bulletin
|
January 1, 1989
Oculomotor abnormalities and their clinical correlates in schizophrenia
G Thaker, B Kirkpatrick, R W Buchanan, et al.
Pharmacological Research Communications
|
May 1, 1985
Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration
E A Parati, M Parenti, V Locatelli, et al.
Schizophrenia Research
|
October 11, 1991
Psychopathology and the question of neurodevelopmental or neurodegenerative disorder
W T Carpenter, R W Buchanan, A Breier, et al.
The American Journal of Psychiatry
|
May 1, 1977
Postsynaptic supersensitivity in schizophrenia
G N Pandey, D L Garver, C Tamminga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1991
Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human
A J Bean, R Elde, Y H Cao, et al.
Clinical Neuropharmacology
|
January 1, 1986
GABA-agonist therapy for Alzheimer's disease
E Mohr, G Bruno, N Foster, et al.
Molecular Psychiatry
|
February 13, 2013
An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors
R N Arey, J F Enwright, S M Spencer, et al.
Psychiatry Research
|
July 1, 1983
Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients
J I Nurnberger, D C Jimerson, S Simmons-Alling, et al.
Page
of 3